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Abstract
Mesenchymal2epithelial transition events are related to embryonic development, tissue construction, and wound healing.
Stem cells are involved in all of these processes, at least in part. However, the direct evidence of mesenchymal2epithelial
transition associated with stem cells is unclear. To determine whether mesenchymal2epithelial transition occurs in liver
development and/or the differentiation process of hepatic stem cells in vitro, we analyzed a variety of murine liver tissues
from embryonic day 11.5 to adults and the colonies derived from hepatic stem/progenitor cells isolated with flow
cytometry. The results of gene expression, immunohistochemistry and Western blot showed that as liver develops, the
expression of epithelial markers such as Cytokeratin18 and E-cadherin increase, while expression of mesenchymal markers
such as vimentin and N-cadherin decreased. On the other hand, in freshly isolated hepatic stem cells, the majority of cells
(65.0%) co-express epithelial and mesenchymal markers; this proportion is significantly higher than observed in
hematopoietic cells, non-hematopoietic cells and non-stem cell fractions. Likewise, in stem cell-derived colonies cultured
over time, upregulation of epithelial genes (Cytokeratin-18 and E-cadherin) occurred simultaneously with downregulation of
mesenchymal genes (vimentin and Snail1). Furthermore, in the fetal liver, vimentin-positive cells in the non-hematopoietic
fraction had distinct proliferative activity and expressed early the hepatic lineage marker alpha-fetoprotein.
Conclusion: Hepatic stem cells co-express mesenchymal and epithelial markers; the mesenchymal2epithelial transition
occurred in both liver development and differentiation of hepatic stem/progenitor cells in vitro. Besides as a mesenchymal
marker, vimentin is a novel indicator for cell proliferative activity and undifferentiated status in liver cells.
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Introduction
Mesenchymal-epithelial transition (MET) events are defined as
those in which mesenchymal cells lose their motile, migratory
properties and acquire cell polarity and adhesion to epithelia.
MET and the reverse process, epithelial mesenchymal transition
(EMT), both occur in normal tissue, including gastrulating and
regenerating tissue, as well as abnormal tissues of fibrotic organs or
tumors [1,2]. Thus, it is necessary to reveal the relationship
between EMT/MET and stem cells. Indeed, EMT drives
mammary epithelial cells to de-differentiate into mammary stem
cells and cancer stem cells which are mesenchymal-like [3].
Moreover, induced pluripotent stem cells (iPSCs) are derived from
mouse embryonic fibroblasts (MEF) by MET at the early stage of
reprogramming [4–6]. These results suggest the possibility that
MET is associated with stem cell activities.
Recent work reported that rat hepatic oval cells (hepatic
progenitors) express mesenchymal markers; this result indicated
but not fully confirmed that MET existed in the process of hepatic
progenitor cell differentiation [7]. On the other hand, hepatocytes,
cholangiocytes and liver are known to undergo EMT under
sophisticated regulation [8–12]. Furthermore, according to the
pathological progression from normal liver to hepatic cirrhosis and
then to hepatic carcinoma, EMT may be associated [8,13–15].
Therefore, MET in hepatic stem cells is important to multiple
processes, including liver development, regeneration, and chronic
liver injury.
In order to identify EMT/MET, vimentin is widely applied as a
mesenchymal indicator [1,3,16–19]. Vimentin is an intermediate
filament protein functionally involved in maintaining the structure
of mesenchymal cells [20]. In addition to serving as a marker in
EMT/MET, vimentin plays a versatile role in cancer cell motility.
In prostate cancer cells, for example, vimentin links the motility
and un-differentiated state of cells [21]. Notwithstanding, in breast
cancer, vimentin mRNA expression is related to mesenchymal cell
shape and motility [22]. In normal tissue injury, depletion of
vimentin delays wound healing by mesenchymal fibroblasts trans-
differentiating into epithelia [23]. Little is known about the
relationship between vimentin expression and normal cell
activation.
To address these questions, we investigated the mesenchymal
characteristics of fetal liver cells and observed MET in developing
mouse liver. Furthermore, based on our previous work [24], we
isolated hepatic stem cells with flow cytometry in order to study
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e17092MET in stem cell differentiation. Importantly, we revealed that
vimentin is associated with proliferative activity in liver cells.
Results
Mesenchymal2epithelial transition is a spontaneous
process involved in mouse liver development
To investigate mesenchymal-epithelial transition in liver
development, we analyzed the phenotype of cells and MET
molecules in developing and adult mouse livers (Figure 1). ED11.5
liver cells are mesenchymal-like with lacking cell2cell connections
(Figure 1A). As development proceeds, from ED11.5 to adult
mouse, liver cells exhibited the change of cell shape from spindle to
polygon, with larger size and tighter intercellular connections
(Figure 1A). Moreover, an expansion of epithelial markers CK8/
18 (Figure 1B and 1D; Table 1) and ZO-1 (Figure S1) but the
reduction of vimentin through liver development were found
(Figure 1B and 1D; Figure S1; Table 1). Similarly, an increasing of
E-cadherin while decreasing of N-cadherin levels were observed
(Figure 1C). N- and E-cadherin co-expressing cells were not found
in adult liver (Figure 1C), demonstrating that not all the
hepatocytes but cells around the central vein express N-cadherin,
in consistent with the previous study [25]. Vimentin-positive cells
in adult liver are only located near the portal vein, showing that
blood vessel comprises these cells (Figure 1B; Figure S1).
Statistically, in ED11.5 and ED13.5 liver, most non-hematopoietic
cells are both epithelial and mesenchymal (CK8/18
+vimentin
+)
(Figure 1B), at a rate of 68.3616.3% and 37.0629.8%,
respectively (Figure 1D; Table 1), in contrast to those of
25.867.1% in ED17.5 and 6.063.2% in adult liver (Figure 1B
and 1C; Table 1). These versatile results provide evidence that
mesenchymal and epithelial co-expressing cells decreased with the
development stages of mouse liver.
After removing the hematopoietic cells, adult mouse liver
showed a significant increasing of mRNAs encoding epithelial
genes CK18 and E-cadherin by 107.8-fold and 8.5-fold,
respectively, but remarkable reducing levels of vimentin, Snail1
and Twist1 gene by 9.4-fold, 3.7-fold, and 16.5-fold, respectively,
to ED11.5 liver (Figure 2A). Similarly, CK8/18 protein was
upregulated from ED11.5 to adult liver with a downregulation of
vimentin protein (Figure 2B). These results indicate that MET
naturally occurs over the course of mouse liver development.
Hepatic stem cells isolated from fetal liver co-express
both epithelial and mesenchymal markers
After confirming that MET occurs in the developing mouse liver,
we attempted to uncover the relationship between MET and hepatic
stem cells, which are related to liver development. In this work we
sorted mouse hepatic stem cells from ED13.5 mouse liver; these stem
cells can form colonies in vitro and reconstruct liver in vivo, consistent
with previous reports [24]. Using this method, we separated mouse
embryonic liver cells into 4 fractions: CD45
+TER119
+ cells
(hematopoietic cells), CD45
2TER119
2 cells (non- hematopoietic
cells), c-Kit
+CD49f
+/lowCD29
+CD45
2TER119
2 cells, and c-
Kit
2CD49f
+/lowCD29
+CD45
2TER119
2 cells, which we considered
to be the fetal liver stem cell fraction (Figure 3A). To figure out which
fraction of cells expressed the epithelial and/or mesenchymal
characteristics, we stained these cells for CK8/18 and vimentin
using the Cytospin. As anticipated, of the 4 sorted cell fractions, the
stem cells had the highest percentage (65.0%) of CK8/18 and
vimentin double positive; this level was 43.3-fold higher than for
hematopoietic cells (1.5%), 8.8-fold higher than non-hematopoietic
cells (7.4%), and 59.1-fold higher than c-Kit
+CD49f
+/low-
CD29
+
CD45
2TER119
2 cells (1.1%) (Figure 3B and 3C). Thus,
the CK8/18 and vimentin double-positive population are mainly
found in the stem cell fraction, which is significantly different from
other cell fractions.
Among the c-Kit
2CD49f
+/lowCD29
+CD45
2TER119
2 cells,
the CK8/18-positive cells are mainly found at a high frequency
as 78.0%, whereas the frequencies were very low in other fractions
(1.9% in hematopoietic cells; 11.1% in non-hematopoietic cells;
1.1% in c-Kit
+CD49f
+/lowCD29
+CD45
2TER119
2 cells). Besides
CK8/18, other epithelia markers such as E-cadherin and ZO-1,
the hepatic lineage marker albumin, the bile duct marker CK7,
and mesenchymal marker N-cadherin were all detected in the
isolated stem cells (Figure S2), showing co-expression of epithelial
and mesenchymal molecules in stem cells. These data demonstrate
that sorted c-Kit
2CD49f
+/lowCD29
+CD45
2TER119
2 hepatic
stem cells are mainly CK8/18 positive and of mesenchymal
character, and thus are distinct from other cells in fetal liver.
Mesenchymal-epithelial transition occurs in stem cell-
derived colonies
To determine whether the mesenchymal and epithelial hepatic
stem cells could experience MET events during stem cell
differentiation, we cultured isolated stem cells for clonal colony
assay and gene expression. Colonies on culture day 21 showed
more expanded staining for epithelial markers albumin, CK8/18,
CK7, ZO-1 and E-cadherin but less vimentin and N-cadherin
than cells on day 0 (Figure 4 and Figure S3). Moreover, co-
expression of CK8/18 and CK7 was detected in stem cell-derived
colonies (Figure S3B), indicating biliary differentiation of CK18-
expressing cells. Even on day 21, there are still cells double positive
for albumin and CK7 (Figure S3D), meaning that they have
hepatocyte and bile duct dual potential.
To further characterize MET in stem cell differentiation, we
performed the quantitative assay for the dynamic changes of E-
cadherin and vimentin, CK8/18 and vimentin expressions in stem
cell-derived colonies in culture (Figure 5). Notably, the frequency
of mesenchymal (vimentin
+) cells decreased from 84.0% on day 0
of culture to 48.3% on day 7 and 9.2% on day 21 (Figure 5A). In
contrast, epithelial (E-cadherin
+) cell frequency increased from day
0 (83.8%) to day 21 (98.1%); and CK8/18 positive cell proportion
increased significantly, from 85.0% on day 0 to 100% on both day
7 and day 21, respectively (Figure 5A). Of these cells, the relative
quantity of vimentin and E-cadherin co-expressing cells decreased
from day 0 (77.9%) to day 7 (41.3%) and day 21 (10.3%); similarly,
vimentin and CK8/18 double-positive cells decreased profoundly
from day 0 (71.3%) to day 7 (48.3%) and day 21 (9.2%) (Figure 5A)
(P,0.05). Furthermore, the albumin
+ hepatocytes were all CK8/
18 positive; these cells were first observed on day 7 (9.0%), and
increased by day 21 (65.0%) (Figure 5A). Additionally, the
differentiated hepatic cells (CK18
+ and albumin
+) in each colony
are surrounded by the mesenchymal-like cells (CK18
+ and
Vimentin
+) in the periphery of the colony (Figure 5), suggesting
that centrally located cells undergo MET and become differen-
tiated earlier than those in peripheral sites.
Relative gene expression measurements in stem cell-derived
colonies confirmed and extended the results of immunocytochem-
istry, demonstrating upregulation of E-cadherin and CK18, but
downregulation of vimentin, Snail1 and Twist1 (Figure 5B). Both
CK18 and E-cadherin (Cdh1) gene expression increased signifi-
cantly from day 0 to day 7 (10.3-fold for CK18 and 1.7-fold for E-
cadherin) and from day 7 to day 21 (1.6-fold for CK18 and 3.2-
fold for E-cadherin) while vimentin and Snail1 except Twist1
demonstrated downward trend in expression between day 0 and
day 21 (1.9-fold for vimentin and 4.5-fold for Snail1) (Figure 5B).
From the results of the colony assay and gene expression
MET in Mouse Hepatic Stem Cell Differentiation
PLoS ONE | www.plosone.org 2 February 2011 | Volume 6 | Issue 2 | e17092Figure 1. Mesenchymal2epithelial transition occurs in developing mouse liver. (A) Phenotype changes of liver cells according to
development stages. Representative images showed hematoxylin/eosin staining of livers from C57BL/6J mice at E11.5, 13.5 and 17.5 and 8 weeks
(Adult) after birth. Right panels showed the magnified pictures. (B) Immunofluorescence for simultaneous detection of CK8/18 (epithelial) and
vimentin (mesenchymal); (C) E-cadherin (epithelial) and N-cadherin (mesenchymal) in livers from mice in (A). Arrows in (B) showed the CK8/18 and
vimentin overlapping cells. (D) The ratio for CK8/18 and/or vimentin expressing non-hematopoietic liver cells from mice in indicated development
stages. Quantitative analyses were based on immunofluorescence staining. These images showed gain of epithelial characters and loss of
mesenchymal characters within mouse liver development. Vim: vimentin. E: embryonic day. BV: Blood vessel. PV: Portal vein. Scale bars=100 mm.
doi:10.1371/journal.pone.0017092.g001
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experience MET during hepatocyte and biliary cell differentiation.
Vimentin positive mesenchymal fetal liver cells are highly
proliferative in vivo
According to the results described above (Figures 1, 2, 3, 4, 5),
hepatic stem cells and a large population of fetal liver cells both
cell types have the capacity to proliferate and differentiate into
mature liver cells, and more importantly, express vimentin. AFP
was first described as a hepatic lineage gene in embryonic
gastrulation [26]. Therefore, to further investigate the correlation
of vimentin and cell proliferative ability, we continued to
characterize vimentin-positive fetal liver cells co-expressing AFP
and BrdU, after removal of hematopoietic cells with CD45 and
TER119 antibodies. As shown in Figure 6A, frequencies of
vimentin and AFP were both very high at ED11.5 comparing with
adult mouse liver (Figure 6A and 6C; Table 1). Almost all the
vimentin-positive cells are AFP-positive at ED11.5 (100%) and
ED13.5 (94.769.2%) mouse liver (Figure 6C), yet the percentage
of AFP-positive in vimentin-expressing cells decreases dramatically
at ED17.5 (15.0610.2%) and disappears altogether in adult mouse
liver (Figure 6C; Table 1). It is worth noticing that almost all the
vimentin-positive cells are BrdU-positive in fetal mouse liver
(ED11.5: 100%, ED13.5: 95.7610.5%, ED17.5: 95.767.5%)
(Figure 6D), as opposed to almost no BrdU-positive cells in adult
mouse liver (0.560.9%). Thus, during the developing of mouse
liver, the number of vimentin-positive cells decreases; meanwhile,
the proportion of vimentin-positive cells that are also AFP- or
BrdU-positive decreases as well (Table 1; Figure 6C and 6D).
Taken together, these measurements provide an in vivo indication
that in mouse liver of ED11.5 and ED13.5, hepatoblasts have
mesenchymal character (vimentin
+) with proliferative activation,
whereas in ED17.5 and adult mouse liver, the number of activated
cells decreases dramatically concomitant with vimentin reduction.
Vimentin, on one hand, has high co-expression with AFP,
suggesting that vimentin is associated with immaturity of the
liver; on the other, vimentin is also linked to cell proliferation, in
that the occurrence of vimentin is related to the liver tissue activity
in the developing process.
Discussion
Different stem cells, including hepatic stem cells, have
mesenchymal characters
In this study, we confirmed that MET occurs during liver
development between ED11.5 and adulthood in the mouse.
Furthermore, by using fluorescence-activated cell sorting, we
obtained evidence that hepatic stem cells, isolated from fetal liver,
spontaneously experience MET during the differentiation into
hepatocytes and biliary cells in vitro. Importantly, distinct from
other cells isolated from fetal liver, hepatic stem cells have both
epithelial and mesenchymal characteristics.
Consistent with our results, stem cells derived from different
sources express mesenchymal characters. For example, stem cells
in epithelial tissue, e.g., mammary stem cells, have been confirmed
as mesenchymal-like [3,27]. This has also been confirmed in
mesenchymal tissue, e.g., muscle stem cells and neural stem cells
[28–30]. Moreover, embryonic stem cells also have a mesenchy-
mal phenotype in the gastrulating embryo [31]. Furthermore,
cancer-initiating cells or cancer stem cells in invasive tumors —
e.g., intestine cancer stem cells [32], mammary cancer stem cells
[3] and prostate cancer stem cells [33] — also have mesenchymal
features. The results reported here may indicate that mesenchymal
capability is necessary for stem cells derived from various sources
to easily proliferate, loosen cell2cell connection, migrate and
differentiate.
Cell activation is associated with vimentin expression
By detecting cells in S phase, BrdU staining can identify
proliferative cells. In our AFP/vimentin and BrdU/vimentin co-
staining experiments, we reveal that the AFP-expressing liver cells
are mesenchymal; furthermore, these cells are in a highly
proliferative state. These results suggest that besides as a marker
in normal and abnormal mesenchymal cells [2,34,35], vimentin
has a novel role in connection with AFP
+ cells and BrdU
+ cells,
indicating these cells are activated for proliferation. Indeed,
vimentin appears to be related to the activation of mesenchymal
cells: for example, in vimentin-deficient mice, the motility and
migration of fibroblasts are impaired [23]. In another report,
vimentin-deficient cells exhibited decreased stiffness as well as
decreased DNA synthesis [36]. More recently, vimentin has been
regarded as mesenchymal cell marker in cancer-related EMT;
drugs that target cancer cell growth also induce vimentin
degradation in cancer cells [37]. These results support our finding
that vimentin is related to cell activation in cancer as well as in
normal tissue.
In addition to being associated with migration and proliferation
of mesenchymal cells, vimentin is an indicator of cell morphology
transformation or cytoskeleton reorganization [38,39]. In mouse
embryonic gastrulation, vimentin increases in fibroblasts that
delaminate through the primitive streak to become mesoderm
[23,40,41], indicating that vimentin plays a role in cell
transformation and tissue construction. Moreover, vimentin is
closely related to loss of polarity of the plasma membrane in fiber
cells [42], cell adhesion and polarization are associated with
decreasing vimentin [43]. Furthermore, in metastatic cancer,
epithelial cancer cells experience EMT concomitant with
upregulation of vimentin as they disassociate from primary
tumors, transform into mesenchyme, and migrate. These mesen-
Table 1. Dynamic expression of hepatic cell types in liver
development.
E11.5 E13.5 E17.5 Adult
Vim+ 69.1619.1
** 40.967.9
* 24.9615.0 6.065.5
CK8/18+ 73.8624.4 89.768.9 72.5619.0 100
AFP+ 71.466.1 69.961.1 18.762.1
** 0
*
BrdU+ 88.164.9
** 42.963.9
** 37.162.9 0.460.4
**
Vim+ CK8/18+ 68.3621.0
ab 39.1618.9 25.867.1
a 6.063.2
b
+ -0 . 8 61.4 1.962.6 0 0
- + 5.567.1
* 52.6624.5 46.7612.8 94.063.2
*
Vim+ AFP+ 69.166.4
bc 39.665.5
de 17.561.8
bd 0
ce
+ -0 2 . 7 62.7 14.861.7 6.063.2
- + 6.964.3 30.368.6
bc 1.260.7
b 0
c
Vim+ BrdU+ 69.166.3
** 40.963.2
a 24.964.7 6.063.2
a
+ -0 2 . 1 62.1 0.360.3 94.062.3
**
- + 20.564.8 2.062.0 18.968.0 0
Four-group comparisons are labeled with *(p,0.05) and **(p,0.01).
Two-group comparisons are labeled with the same alphabet a (p,0.05) and b,
c, d or e (p,0.01).
Percentage of vimentin, CK8/18, AFP and/or BrdU expressing cells in non-
hematopoietic liver cells from mice at indicated development stages. Statistical
analyses were done in different liver development.
doi:10.1371/journal.pone.0017092.t001
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tion of vimentin at metastasis sites [3,16,44–46]. Interestingly, it is
reported that cytoplasmic vimentin and keratin5/14 share a
similar coil structure, though the function of this similarity is not
clear [47], suggesting the possibility of a vimentin-to-keratin
transition within the same cell, consistent with our observations of
MET. The reorganization of vimentin molecular structure in the
cytoplasm may explain the plasticity of stem cells and the
transformation of mesenchymal cells into epithelial cells.
Although the link between stem cells and vimentin-positive cells
in fetal liver has not been completely elucidated, we suggest that
vimentin is a critical indicator for activated cells experiencing
MET. Accordingly, because of the elastic state of stem cells, our
results provide a hint that MET in stem cells indicates
rearrangement of cytoskeleton as well. During the process of
inactivating mesenchymal cells or the developing fetal liver, the
number of vimentin-positive cells decreased (Figures 6 and 7).
Mesenchymal epithelial transition generates cell
inactivation
In this study of MET, the adult liver expressed very low rate of
vimentin, AFP and BrdU positive, suggesting that adult liver cells
are in quiescent state. Based on the preceding statements, it can be
inferred that MET drives stem cells into a quiescent state, whereas
EMT is associated with reactivation or reprogramming of
epithelial cells [3,45] (Figure 7). MET is also involved in other
cell inactivation, for example, in wound healing, activated
fibroblasts lose cell polarity, migrate into the wound site and
differentiate into keratinocytes [23], a process driven by MET.
During metastasis tumor invasion, epithelial tumor cells become
mesenchymal-like and disassociate from the primary tumor,
indicating that epithelial cell activation and proliferation [17] are
driven by EMT. Subsequently, those de-differentiated mesenchy-
mal cells colonize and differentiate into secondary carcinomas
[17]. Comparing with invasive sites, the central area of many
metastases showed reduced expression of nuclear b-catenin [48],
indicating the inactivated state of the MET driven cells. Take
together, it is suggested that in stem cell differentiation, wound
healing and malignant tumor [32], MET process is related with
cells changing from mesenchymal, de-polarized, proliferative and
migrating state, to epithelial, polarized, differentiated, adhesive
and inactivation state.
Mesenchymal epithelial transition in hepatic stem cell
reflects a natural process in vitro
There is still some controversy about the relationship between
the tissue microenvironments and EMT. One group claimed that
cytokines such as EGF and HGF in cell culture can induce
Figure 2. In vivo quantitative assay for mesenchymal2epithelial transition in liver developing of mouse. (A) Relative mRNA expressions
showed the increasing of Cdh1 (E-cadherin), CK18, and decreasing of vimentin, Snail1 and Twist1 at different developmental stages. RNA was
extracted from non-hematopoietic liver cells of C57BL/6J mice. Error bars represented standard errors in three independent experiments. *P,0.05,
**P,0.01. (B) Western blot for CK8/18 increasing and vimentin decreasing in non-hematopoietic liver cells of E11.5, 13.5 and adult mice. Actin was
used as an internal control. E-cad: E-cadherin.
doi:10.1371/journal.pone.0017092.g002
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addition, other findings in pancreatic cells suggest that EMT is not
involved in the origin of pancreatic mesenchymal stem cells
(MSCs) [50]. In their report [50], EMT depended on the culture
condition, and some of the vimentin single-positive cells are
directly derived from the mesenchymal cells which are not
experiencing EMT. Whether MET is influenced by these
microenvironments is still unknown. In contrast, on one hand,
we confirmed that MET occurs during mouse liver development
both in vivo and in vitro (Figures 1, 2, 3, 4, 5). On the other hand, in
stem cell colonies, the frequency of vimentin-positive cells
decreased over the course of time in culture, and vimentin-
positive but CK8/18-negative cells disappeared after day 7
(Figures. 4 and 5A). These dynamic transitions indicate that the
vimentin-positive mesenchymal cells differentiated into epithelial
cells. Additionally, we found that differentiated hepatocytes
(albumin-positive) are derived from CK8/18- and vimentin-
double-positive cells (Figures 4 and 5A), demonstrating that
MET occurs naturally in stem cell differentiation.
Conclusion
In summary, from the view of MET in this study, our results
confirm the concept that MET is a normal process associated with
stem cell differentiation and liver development. This may offer the
promise of specifying the hepatic stem cells in liver regeneration
and chronic liver injury, in which MET/EMT are involved. More
importantly, to our knowledge, direct evidence shows that in
addition to serving as a marker for mesenchymal cells, vimentin
can also reveal cell activation and proliferation state. These results
provide further insights that will help to elucidate the effects of
vimentin in hepatic stem cell differentiation and progression of
liver pathology.
Materials and Methods
Animals and cell preparation
C57BL/6J mice at embryonic days (ED) 11.5, 13.5, 17.5 and 8
weeks (Adult) after birth were purchased from Japan SLC (Tokyo,
Japan). All animal experimentation was conducted in accordance
with the Guidelines for Proper Conduct of Animal Experiments
(Science Council of Japan), and all protocols were approved by
institutional review board of Animal Research Center, Yokohama
City University School of Medicine (09-48). For the in vitro
fluorescent activated cell sorting (FACS)H assays, single cell
suspensions of liver cells were prepared from fetal mice.
Embryonic liver was treated with 0.1% trypsin21 mM ethylene
glycol tetraacetic acid (EGTA) in order to dissociate cells, as
described [51].
Cell sorting and culture
ED13.5 fetal mouse liver cells were incubated at 4uC for 30
minutes with biotinylated anti-CD45 (PharMingen, San Jose, CA)
and TER119 mAb (PharMingen) phycoerythrin-conjugated anti-
CD49f mAb (PharMingen), fluorescein isothiocyanate- conjugated
anti-CD29 mAb (PharMingen), allophycocyanin-conjugated anti-c-
KitmAb(PharMingen).After3 washings with stainingmedium (3%
FCS in PBS), cells were stained with streptavidin-labeled APC-Cy7
(PharMingen) at 4uC for 20 minutes. Finally, cells were washed 3
times and resuspended in staining medium containing propidium
iodide (1 mg/mL) (Sigma, St Louis, MO). Labeled cells were
analyzed and separated with MoFlo (DakoCytomation, Glostrup,
Denmark) and Summit version 4.0 software (DakoCytomation).
After removal of hematopoietic cells by CD45 and TER119
antibodies, four cell fractions are compared, CD45
+TER119
+,
CD45
2TER119
2,c 2kit
+CD49f
+CD29
+CD45
2TER119
2,a n d
c2kit
2CD49f
+CD29
+CD45
2TER119
2 subpopulation which are
reported as hepatic stem cell fraction [24]. Cells were cultured on
type IV collagen coated 6-well plates (Becton Dickinson, San Jose,
CA) at a density of 500cells/cm
2 in our standard culture medium
[51]. Human recombinant hepatocyte growth factor (HGF) (50 ng/
mL) (Sigma, St Louis, MO) and epidermal growth factor (EGF)
(20 ng/mL) (Sigma) were added 24 hours after culture initiation.
Cells on culture days 0, 1, 7 and 21 are collected for relative mRNA
expression and immunofluorescence analyses.
Histology and immunofluorescence
Tissues were fixed with 10% neutral formalin and embedded in
paraffin. Histological 3-mm-thick serial cross sections were cut at
50-mm intervals and stained with hematoxylin and eosin. Cytospin
samples were sorted on MAS coated glass slides (Matsunami glass,
Japan), followed by centrifugation at 2000rpm, 4uC for 5 min. For
in vivo assays, C57BL/6J mouse livers from different developmen-
tal stages were embedded in Tissue-TekH OCT compound
(Sakura Finetek, Japan). For immunofluorescence assays, Cytos-
pin, cultured cells and cryostat liver tissue sections were fixed with
2% Paraformaldehyde (PFA) at 4uC for 20 minutes, and washed in
PBS including 0.05% Tween 20 (Wako). Nonspecific binding was
blocked with 10% nonimmune serum of a species from which the
secondary antibody had been obtained. Samples were incubated
with primary antibodies and second antibodies as described in
Table S1. After final washing, cells were nuclei were stained blue
with DAPI and viewed with a ZEISS Axio Imager.M1
microscope.
RNA isolation and Real-time PCR
Liver cells were treated as described above. Non-hematopoi-
etic cells were collected after the removal of CD45
+TER119
+
labeled hematopoietic cells by flow cytometry. Total RNA was
isolated with ISOGEN (Nippon gene, Tokyo, Japan), treated
with DNaseI (Invitrogen, Carlsbad, CA) to get rid of genome
DNA and complementary DNA (cDNA) was synthesized using
the SuperScriptIII Reverse Transcriptase (Invitrogen), as
described [24]. Quantitative reverse transcript PCR analysis
was performed using the ABI PRISM7700 real-time PCR
system (Applied Biosystems, Foster city, CA). Expression levels
were normalized to that of glyceradehyde-3-phosphate dehy-
drogenase (GAPDH). TaqMan PCR probes (Applied Biosys-
tems) are listed in Table S2.
Figure 3. Isolation and characterization of hepatic stem cells of mouse. (A) Hepatic stem cell sorting with flow cytometry. E13.5 mouse liver
cells were sorted with gates set for c-kit
2CD29
+CD49f
+CD45
2TER119
2 in order to isolate hepatic stem cells as mentioned in Materials and Methods.
(B) Immunofluorescence for CK8/18 and vimentin expression in different isolated cell fractions with flow cytometry: CD45
+Ter119
+cells
(hematopoietic cells), CD45
2Ter119
2cells (non-hematopoietic cells), c-Kit
+CD49f
+/lowCD29
+CD45
2Ter119
2 cells and c-Kit
2CD49f
+/low-
CD29
+
CD45
2Ter119
2 cells (hepatic stem cells). Samples were collected by cytospin. (C) Quantifications of CK8/18- and vimentin-expressing cell
distributions in the different isolated cell fractions described in (B). Note that the CK8/18
+vimentin
+ co-expression cells were main population in stem
cell fraction. Error bars represent standard errors in three independent experiments. Arrows showed the cell in magnified pictures. Scheffe’s F test.
*P,0.05, **P,0.01. Scale bars=20 mm.
doi:10.1371/journal.pone.0017092.g003
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Non-hematopoietic liver cells (CD45
2TER119
2) were isolated
with IMag Streptavidin Particles Plus (BD Biosciences, San Jose,
CA) under manufacture’s instructions. Cells were lysed in the
presence of 50 mM Tris, pH 7.5, 150 mM NaCl, 0.1% SDS,
0.5% Deoxycholic acid sodium salt and 1% NP-40 on ice. Thirty
micrograms of total protein from each sample was fractionated on
a 10% Acrylamide Gel and transferred to PVDF membranes.
Figure 4. Mesenchymal2epithelial transition occurred in stem cell-derived colonies during culture. Immunofluorescence for stem cells
and stem cell-derived colonies at indicated culture days. (A) CK8/18 and vimentin transition accompanied with hepatic differentiation of stem cells
into albumin positive cells; (B) E-cadherin and N-cadherin, vimentin transition accompanied with hepatic differentiation of stem cells. Scale
bars=100 mm.
doi:10.1371/journal.pone.0017092.g004
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PLoS ONE | www.plosone.org 8 February 2011 | Volume 6 | Issue 2 | e17092Figure 5. In vitro quantitative assay for mesenchymal2epithelial transition of stem cell-derived colonies. (A) Quantification of
immunofluorescence in cultured stem cells on day 0 and stem cell derived colonies on days 7 and 21. Upper panel, E-cadherin and vimentin
expressing cell assay (dashed regions indicate double-negative cells); lower panel, CK8/18, vimentin and albumin assay. Graph showed quantification
of three independent experiments. (B) Relative mRNA expressions in cultured stem cells and stem cell derived colonies. It showed up-regulation of
epithelial genes, Cdh1 (E-cadherin) and CK18, and down-regulation of mesenchymal genes, vimentin, Snail1 and Twist1 during stem cell
differentiation according to the passing by of culture time. Error bars represent standard errors in three independent experiments. **P,0.01. Alb:
albumin. E-cad: E-cadherin.
doi:10.1371/journal.pone.0017092.g005
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PLoS ONE | www.plosone.org 9 February 2011 | Volume 6 | Issue 2 | e17092Figure 6. Vimentin-positive mesenchymal fetal liver cells are highly proliferative in vivo. (A) Representative images of dual
immunofluorescence of AFP and vimentin; (B) BrdU and vimentin in mice livers at different developmental stages. AFP and BrdU expressions
decreased accompanied with vimentin reduction. (C) and (D) represented the relative quantitative assay of non-hematopoietic cells in (A) and (B)
respectively. These results showed that AFP positive liver cells also expressed vimentin, and the vimentin
+ cells are highly proliferative (BrdU
+). Scale
bars=100 mm.
doi:10.1371/journal.pone.0017092.g006
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CK8/18 (PROGEN, Germany) and anti-b-actin (Cell Signaling,
Beverly, MA) antibodies. Proteins were visualized using the ECL
detection reagent from Amersham (GE Healthcare, UK).
DNA synthesis assay
BrdU (50 mg/kg body weight) (Sigma) dissolved in PBS with
7 mM NaOH was injected intraperitoneally into mice 6 h before
sacrifice. After being fixed with 2% PFA and washed with 0.05%
Tween 20 in PBS, liver frozen sections were treated with 2N HCl
and neutralized in 0.1 M sodium tetraborate (pH 8.5). The
sections were then stained with anti-BrdU antibody (BD
Pharmingen, San Jose, CA) as described [52] using Alexa
FluorH488 goat anti-mouse IgG1 (Invitrogen, Carlsbad, CA) as a
secondary antibody for visualization.
Statistical analysis
All data are presented as mean6SD. Scheffe’s F test and
Bonferroni/Dunn correction were used to compare multiple
groups of data. P,0.05 and P,0.01 were considered as
statistically significant and great significant respectively.
Supporting Information
Figure S1 Mesenchymal2epithelial transition occurs in
mouse liver development. Representative images of dual
immunofluorescence of epithelial (ZO-1) and mesenchymal
(vimentin) cells in C57BL/6J mice livers at different developmen-
tal stages. Scale bars=100 mm.
(TIF)
Figure S2 Hepatic stem cells are both epithelial- and
mesenchymal-like. (A) Immunofluorescence of hepatocyte
marker albumin, biliary cell marker CK7 and vimentin; (B)
CK8/18, CK7 and vimentin; (C) E-cadherin, N-cadherin and
vimentin; (D) E-cadherin, ZO-1 and vimentin expression in
isolated c-Kit
2CD49f
+/lowCD29
+CD45
2Ter119
2 hepatic stem
cells with flow cytometry. Scale bars=50 mm.
(TIF)
Figure S3 Mesenchymal2epithelial transition occurs in
stem cell-derived colonies during culture. (A) During
culture day 1 to day 21, stem cells and stem cell-derived colonies
were immunostained with albumin, CK7 and vimentin; (B) CK8/
18, CK7 and vimentin; or (C) E-cadherin, ZO-1 and vimentin. (D)
Partially differentiated stem cell colonies were indicated. Arrow-
head, albumin and CK7 co-expressing cells. Scale bars=100 mm.
(TIF)
Table S1 List of Antibodies. 1
st and 2
nd antibodies used in
the immunofluorescence experiments are listed.
(DOC)
Table S2 List of TaqMan probes. TaqMan probes used for
detection of the relative gene expressions are listed.
(DOC)
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